Advertising Prescription Drugs To Consumers In Europe Bad For Public Health, Say Experts
As the European parliament looks at the possibility of allowing pharmaceutical companies more freedom in direct-to-consumer prescription drug promotion, experts caution in this week’s British Medical Journal (BMJ) that this could be detrimental for public health. [click link for full article]
More: continued here
Filed under: Pharma Industry on October 5th, 2007